Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993189priorityCriticalpatent/ECSP993189A/en
Publication of ECSP993189ApublicationCriticalpatent/ECSP993189A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Enzymes And Modification Thereof
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención describe la identificación de nuevos inhibidores de IMPDH (inosina-5¿-monofosfato deshidorgenasa). Los compuestos y composiciones farmacéuticas descritos aquí son útiles para tratar o prevenir padecimientos asociados con IMPDH, tal como rechazo de transplante y enfermedades y enfermedades autoinmunes.The present invention describes the identification of new IMPDH inhibitors (inosine-5¿-monophosphate dehydrogenase). The compounds and pharmaceutical compositions described herein are useful for treating or preventing conditions associated with IMPDH, such as transplant rejection and autoimmune diseases and conditions.
ECSP9931891999-10-221999-10-22
NEW ENZYME INHIBITORS IMPDH
ECSP993189A
(en)
Substituted homopiperidylbenzimidazole analog compounds as authentic relaxants, process for preparing same, pharmaceutical composition and process for preparing it.